Biogen (BIIB) Raw Materials (2010 - 2018)

Biogen has reported Raw Materials for 9 years, with the latest figure at $196.3 million in Q4 2018.

• On a quarterly basis, Raw Materials rose 20.87% year-over-year to $196.3 million in Q4 2018; TTM through Dec 2018 was $196.3 million, a 20.87% increase from a year earlier, with the FY2018 full-year figure at $196.3 million, up 20.87% from the prior year.
• Raw Materials was $196.3 million for Q4 2018 at Biogen, up from $162.4 million in the prior quarter.
• The five-year high for Raw Materials was $213.0 million in Q4 2015, with the low at $128.3 million in Q4 2014.
• Average Raw Materials over 5 years is $174.1 million, with a median of $170.4 million recorded in 2016.
• The sharpest annual moves came in 2015 and 2016: Raw Materials surged 66.02% in 2015, then fell 20.0% in 2016.
• Over 5 years, Raw Materials stood at $128.3 million in 2014, then soared by 66.02% to $213.0 million in 2015, then declined by 20.0% to $170.4 million in 2016, then fell by 4.69% to $162.4 million in 2017, then climbed by 20.87% to $196.3 million in 2018.
• The last three Raw Materials figures came in at $196.3 million (Q4 2018), $162.4 million (Q4 2017), and $170.4 million (Q4 2016), per Business Quant data.